idea 601 words KG: SGLT2 2026-03-24
kind:ideakind:therapy-ideasection:ideasstate:published
Contents

SGLT2 Inhibitor Neuroprotection Therapy

Knowledge Graph

Related Hypotheses (28)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68
Transcriptional Autophagy-Lysosome Coupling
Score: 0.66
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65
CYP46A1 Overexpression Gene Therapy
Score: 0.63

Related Analyses (18)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived

Related Experiments (2)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40

See Also (2)

MTOR Gene
gene · KG edge: regulates
mTOR Signaling Dysregulation in Progressive Supranuclea
event · KG edge: regulates

Knowledge Graph (12 edges)

SGLT2 involved_in glucose metabolism
SGLT2 participates_in ferroptosis
SGLT2 inhibits VDAC1
SGLT2 inhibits neurodegeneration
SGLT2 expressed_in stem cells
SGLT2 participates_in oxidative stress response
SGLT2 participates_in lipid metabolism
SGLT2 participates_in senescence
SGLT2 inhibits Parkinson's disease
SGLT2 regulates MTOR